Original Research
Published on 10 Feb 2026
Cost-effectiveness of perioperative durvalumab plus FLOT for resectable gastric and gastroesophageal junction adenocarcinoma in the United States
in Cancer Immunity and Immunotherapy
- 168 views
Original Research
Published on 10 Feb 2026
in Cancer Immunity and Immunotherapy
Perspective
Published on 10 Feb 2026
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 10 Feb 2026
in Aquatic Physiology
Correction
Published on 10 Feb 2026
in Pediatric Endocrinology
Original Research
Published on 10 Feb 2026
in Comparative Immunology
Editorial
Published on 10 Feb 2026
in Animal Nutrition and Metabolism
Original Research
Published on 10 Feb 2026
in Children and Health
Editorial
Published on 10 Feb 2026
in One Health
Case Report
Published on 10 Feb 2026
in Pathology
Original Research
Published on 10 Feb 2026
in Digital Manufacturing
Core Concept
Published on 10 Feb 2026
in Biodiversity
Original Research
Published on 10 Feb 2026
in Microbial Immunology
Review
Published on 10 Feb 2026
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Systematic Review
Published on 10 Feb 2026
in Schizophrenia
Opinion
Published on 10 Feb 2026
in Mood Disorders
Perspective
Published on 10 Feb 2026
in Children and Health